Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.05 - $5.5 $43,906 - $59,625
-10,841 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$25.47 - $39.69 $26,132 - $40,721
1,026 Added 10.45%
10,841 $420,000
Q1 2020

May 13, 2020

SELL
$31.65 - $45.3 $1,519 - $2,174
-48 Reduced 0.49%
9,815 $341,000
Q4 2019

Feb 14, 2020

BUY
$18.94 - $49.53 $186,805 - $488,514
9,863 New
9,863 $453,000

Others Institutions Holding APRE

About Aprea Therapeutics, Inc.


  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.